Abstract: Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation and hepatocyte injury and constitutes hepatic manifestation of the metabolic syndrome. The pathogenesis of NASH is complex and implicates cross-talk between different metabolically active sites, such as liver and adipose tissue. Obesity is considered a chronic low-grade inflammatory state and the liver has been recognized as being an “immunological organ”. The complex role of the immune system in the pathogenesis of NASH is currently raising great interest, also in view of the possible therapeutic potential of immunotherapy in NASH. This review focuses on the disturbances of the cells constituting the innate and adaptive immune system ...
Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disease worldwide, both...
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD), ...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation and...
The low grade inflammatory state present in obesity promotes the progression of Non-Alcoholic Fatty ...
Non-alcoholic steatohepatitis (NASH) is a disorder marked by alterations in hepatic lipid homeostasi...
International audienceThe incidence of non-alcoholic fatty liver disease (NAFLD) has increased signi...
Abstract Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic f...
International audienceNon-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifest...
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public hea...
Abstract: Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease...
Nonalcoholic fatty liver disease (NAFLD) is a disease spectrum that spans simple steatosis, fibrosis...
Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis and inflammation and, in ...
International audienceNon alcoholic steatohepatitis (NASH) is the more severe form of nonalcoholic f...
Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis and inflammation and, in...
Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disease worldwide, both...
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD), ...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation and...
The low grade inflammatory state present in obesity promotes the progression of Non-Alcoholic Fatty ...
Non-alcoholic steatohepatitis (NASH) is a disorder marked by alterations in hepatic lipid homeostasi...
International audienceThe incidence of non-alcoholic fatty liver disease (NAFLD) has increased signi...
Abstract Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic f...
International audienceNon-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifest...
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public hea...
Abstract: Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease...
Nonalcoholic fatty liver disease (NAFLD) is a disease spectrum that spans simple steatosis, fibrosis...
Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis and inflammation and, in ...
International audienceNon alcoholic steatohepatitis (NASH) is the more severe form of nonalcoholic f...
Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis and inflammation and, in...
Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disease worldwide, both...
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD), ...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...